{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:29:39Z","timestamp":1786588179038,"version":"build-2736575974"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"DOI":"10.1007\/s10555-026-10367-6","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:26:40Z","timestamp":1786588000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lung tumour secretome and extracellular vesicles: mechanisms, biomarkers, and therapeutic opportunities"],"prefix":"10.1007","volume":"45","author":[{"given":"Kota","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzheng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme Stuart","family":"Cottrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1686-130X","authenticated-orcid":false,"given":"Darius","family":"Widera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"10367_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2024.102693","volume":"93","author":"J Zhou","year":"2024","unstructured":"Zhou, J., et al. (2024). Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN. Cancer Epidemiology, 93, Article 102693. https:\/\/doi.org\/10.1016\/j.canep.2024.102693","journal-title":"Cancer Epidemiology"},{"issue":"13","key":"10367_CR2","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1097\/cm9.0000000000002529","volume":"136","author":"C Li","year":"2023","unstructured":"Li, C., et al. (2023). Global burden and trends of lung cancer incidence and mortality. Chinese Medical Journal (English Edition), 136(13), 1583\u20131590. https:\/\/doi.org\/10.1097\/cm9.0000000000002529","journal-title":"Chinese Medical Journal (English Edition)"},{"issue":"2","key":"10367_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1021\/acs.jproteome.5b00819","volume":"15","author":"R Hu","year":"2016","unstructured":"Hu, R., et al. (2016). Quantitative secretomic analysis identifies extracellular protein factors that modulate the metastatic phenotype of non-small cell lung cancer. Journal of Proteome Research, 15(2), 477\u2013486. https:\/\/doi.org\/10.1021\/acs.jproteome.5b00819","journal-title":"Journal of Proteome Research"},{"issue":"8","key":"10367_CR4","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/cncr.35128","volume":"130","author":"TB Kratzer","year":"2024","unstructured":"Kratzer, T. B., et al. (2024). Lung cancer statistics, 2023. Cancer, 130(8), 1330\u20131348. https:\/\/doi.org\/10.1002\/cncr.35128","journal-title":"Cancer"},{"key":"10367_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16111967","author":"AP Carreca","year":"2024","unstructured":"Carreca, A. P., et al. (2024). Extracellular vesicles in lung cancer: Implementation in diagnosis and therapeutic perspectives. Cancers. https:\/\/doi.org\/10.3390\/cancers16111967","journal-title":"Cancers"},{"issue":"10","key":"10367_CR6","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s11606-020-05951-7","volume":"35","author":"RM Hoffman","year":"2020","unstructured":"Hoffman, R. M., et al. (2020). Lung cancer screening with low-dose CT: A meta-analysis. Journal of General Internal Medicine, 35(10), 3015\u20133025. https:\/\/doi.org\/10.1007\/s11606-020-05951-7","journal-title":"Journal of General Internal Medicine"},{"issue":"1","key":"10367_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12890-019-0883-x","volume":"19","author":"KL Huang","year":"2019","unstructured":"Huang, K. L., et al. (2019). Effects of low-dose computed tomography on lung cancer screening: A systematic review, meta-analysis, and trial sequential analysis. BMC Pulmonary Medicine, 19(1), 126. https:\/\/doi.org\/10.1186\/s12890-019-0883-x","journal-title":"BMC Pulmonary Medicine"},{"key":"10367_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11061040","author":"T Hunger","year":"2021","unstructured":"Hunger, T., et al. (2021). Lung cancer screening with low-dose CT in smokers: A systematic review and meta-analysis. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics11061040","journal-title":"Diagnostics"},{"key":"10367_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061384","author":"P Gilson","year":"2022","unstructured":"Gilson, P., Merlin, J. L., & Harl\u00e9, A. (2022). Deciphering tumour heterogeneity: From tissue to liquid biopsy. Cancers. https:\/\/doi.org\/10.3390\/cancers14061384","journal-title":"Cancers"},{"key":"10367_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17213474","author":"SB Urtecho","year":"2025","unstructured":"Urtecho, S. B., et al. (2025). Liquid biopsy in lung cancer: Tracking resistance to targeted therapies. Cancers. https:\/\/doi.org\/10.3390\/cancers17213474","journal-title":"Cancers"},{"key":"10367_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1286821","volume":"13","author":"JK Luu","year":"2023","unstructured":"Luu, J. K., et al. (2023). Characterizing the secretome of EGFR mutant lung adenocarcinoma. Frontiers in Oncology, 13, Article 1286821. https:\/\/doi.org\/10.3389\/fonc.2023.1286821","journal-title":"Frontiers in Oncology"},{"key":"10367_CR12","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1038\/ncomms3980","volume":"4","author":"C Villarroya-Beltri","year":"2013","unstructured":"Villarroya-Beltri, C., et al. (2013). Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nature Communications, 4, 2980. https:\/\/doi.org\/10.1038\/ncomms3980","journal-title":"Nature Communications"},{"key":"10367_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering6010007","author":"TA Hartjes","year":"2019","unstructured":"Hartjes, T. A., et al. (2019). Extracellular vesicle quantification and characterization: Common methods and emerging approaches. Bioengineering. https:\/\/doi.org\/10.3390\/bioengineering6010007","journal-title":"Bioengineering"},{"key":"10367_CR14","doi-asserted-by":"publisher","unstructured":"Liu, Q., et al., (2017) Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Oncotarget, 8(8), 13048\u201313058 https:\/\/doi.org\/10.18632\/oncotarget.14369","DOI":"10.18632\/oncotarget.14369"},{"issue":"3","key":"10367_CR15","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.21037\/tlcr-20-1255","volume":"10","author":"X Li","year":"2021","unstructured":"Li, X., et al. (2021). Tumor-associated macrophages secret exosomal miR-155 and miR-196a-5p to promote metastasis of non-small-cell lung cancer. Translational Lung Cancer Research, 10(3), 1338\u20131354. https:\/\/doi.org\/10.21037\/tlcr-20-1255","journal-title":"Translational Lung Cancer Research"},{"issue":"8","key":"10367_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0295-2","volume":"51","author":"DH Kim","year":"2019","unstructured":"Kim, D. H., et al. (2019). Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer. Experimental and Molecular Medicine, 51(8), 1\u201313. https:\/\/doi.org\/10.1038\/s12276-019-0295-2","journal-title":"Experimental and Molecular Medicine"},{"issue":"7578","key":"10367_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino, A., et al. (2015). Tumour exosome integrins determine organotropic metastasis. Nature, 527(7578), 329\u2013335. https:\/\/doi.org\/10.1038\/nature15756","journal-title":"Nature"},{"issue":"7718","key":"10367_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen, G., et al. (2018). Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature, 560(7718), 382\u2013386. https:\/\/doi.org\/10.1038\/s41586-018-0392-8","journal-title":"Nature"},{"issue":"2","key":"10367_CR19","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/jcmm.14838","volume":"24","author":"X Liu","year":"2020","unstructured":"Liu, X., et al. (2020). Exosomes transmit T790M mutation-induced resistance in EGFR-mutant NSCLC by activating PI3K\/AKT signalling pathway. Journal of Cellular and Molecular Medicine, 24(2), 1529\u20131540. https:\/\/doi.org\/10.1111\/jcmm.14838","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"40","key":"10367_CR20","doi-asserted-by":"publisher","first-page":"24534","DOI":"10.1074\/jbc.M115.679217","volume":"290","author":"L Montermini","year":"2015","unstructured":"Montermini, L., et al. (2015). Inhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA content. Journal of Biological Chemistry, 290(40), 24534\u201324546. https:\/\/doi.org\/10.1074\/jbc.M115.679217","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10367_CR21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.18632\/oncotarget.2671","volume":"6","author":"J Li","year":"2015","unstructured":"Li, J., et al. (2015). Reciprocal activation between IL-6\/STAT3 and NOX4\/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells. Oncotarget,6(2), 1031\u20131048. https:\/\/doi.org\/10.18632\/oncotarget.2671","journal-title":"Oncotarget"},{"issue":"1","key":"10367_CR22","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1186\/s12885-023-11428-7","volume":"23","author":"A Amin","year":"2023","unstructured":"Amin, A., et al. (2023). Dissection of paracrine\/autocrine interplay in lung tumor microenvironment mimicking cancer cell-monocyte co-culture models reveals proteins that promote inflammation and metastasis. BMC Cancer, 23(1), 926. https:\/\/doi.org\/10.1186\/s12885-023-11428-7","journal-title":"BMC Cancer"},{"issue":"6","key":"10367_CR23","doi-asserted-by":"publisher","first-page":"9811","DOI":"10.3892\/ol.2018.8604","volume":"15","author":"C Jing","year":"2018","unstructured":"Jing, C., et al. (2018). Exosome-mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR-21. Oncology Letters, 15(6), 9811\u20139817. https:\/\/doi.org\/10.3892\/ol.2018.8604","journal-title":"Oncology Letters"},{"issue":"1","key":"10367_CR24","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s42003-025-09004-9","volume":"8","author":"AK Kalvala","year":"2025","unstructured":"Kalvala, A. K., et al. (2025). Extracellular vesicles modulate integrin signaling and subcellular energetics to promote pulmonary lymphangioleiomyomatosis metastasis. Communications Biology, 8(1), 1623. https:\/\/doi.org\/10.1038\/s42003-025-09004-9","journal-title":"Communications Biology"},{"key":"10367_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01479","volume":"10","author":"S Oggero","year":"2019","unstructured":"Oggero, S., Austin-Williams, S., & Norling, L. V. (2019). The contrasting role of extracellular vesicles in vascular inflammation and tissue repair. Frontiers in Pharmacology, 10, Article 1479. https:\/\/doi.org\/10.3389\/fphar.2019.01479","journal-title":"Frontiers in Pharmacology"},{"issue":"6","key":"10367_CR26","doi-asserted-by":"publisher","first-page":"H1181","DOI":"10.1152\/ajpheart.00579.2020","volume":"319","author":"V Chatterjee","year":"2020","unstructured":"Chatterjee, V., et al. (2020). Extracellular vesicles: New players in regulating vascular barrier function. American Journal of Physiology, Heart and Circulatory Physiology,319(6), H1181-h1196. https:\/\/doi.org\/10.1152\/ajpheart.00579.2020","journal-title":"American Journal of Physiology, Heart and Circulatory Physiology"},{"issue":"7547","key":"10367_CR27","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature14336","volume":"520","author":"AC Obenauf","year":"2015","unstructured":"Obenauf, A. C., et al. (2015). Therapy-induced tumour secretomes promote resistance and tumour progression. Nature, 520(7547), 368\u2013372. https:\/\/doi.org\/10.1038\/nature14336","journal-title":"Nature"},{"key":"10367_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.764151","volume":"9","author":"X Guo","year":"2021","unstructured":"Guo, X., et al. (2021). Cancer-associated fibroblasts promote migration and invasion of non-small cell lung cancer cells via miR-101-3p mediated VEGFA secretion and AKT\/eNOS pathway. Frontiers in Cell and Developmental Biology, 9, Article 764151. https:\/\/doi.org\/10.3389\/fcell.2021.764151","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"5","key":"10367_CR29","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3892\/ijo.2014.2310","volume":"44","author":"R-Y Liu","year":"2014","unstructured":"Liu, R.-Y., et al. (2014). JAK\/STAT3 signaling is required for TGF-\u03b2-induced epithelial-mesenchymal transition in lung cancer cells. International Journal of Oncology, 44(5), 1643\u20131651. https:\/\/doi.org\/10.3892\/ijo.2014.2310","journal-title":"International Journal of Oncology"},{"issue":"Pt 2","key":"10367_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.128412","volume":"256","author":"YH Zhang","year":"2024","unstructured":"Zhang, Y. H., et al. (2024). A novel lung cancer stem cell extracellular vesicles lncRNA ROLLCSC modulate non-stemness cancer cell plasticity through miR-5623-3p and miR-217-5p targeting lipid metabolism. International Journal of Biological Macromolecules,256(Pt 2), Article 128412. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128412","journal-title":"International Journal of Biological Macromolecules"},{"issue":"1","key":"10367_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3816\/CLC.2009.n.006","volume":"10","author":"G Rabinowits","year":"2009","unstructured":"Rabinowits, G., et al. (2009). Exosomal microRNA: A diagnostic marker for lung cancer. Clinical Lung Cancer, 10(1), 42\u201346. https:\/\/doi.org\/10.3816\/CLC.2009.n.006","journal-title":"Clinical Lung Cancer"},{"issue":"3","key":"10367_CR32","doi-asserted-by":"publisher","DOI":"10.1088\/1478-3975\/ab0032","volume":"16","author":"J Xing","year":"2019","unstructured":"Xing, J., & Tian, X. J. (2019). Investigating epithelial-to-mesenchymal transition with integrated computational and experimental approaches. Physical Biology, 16(3), Article 031001. https:\/\/doi.org\/10.1088\/1478-3975\/ab0032","journal-title":"Physical Biology"},{"issue":"4","key":"10367_CR33","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.bpj.2013.07.011","volume":"105","author":"XJ Tian","year":"2013","unstructured":"Tian, X. J., Zhang, H., & Xing, J. (2013). Coupled reversible and irreversible bistable switches underlying TGF\u03b2-induced epithelial to mesenchymal transition. Biophysical Journal, 105(4), 1079\u20131089. https:\/\/doi.org\/10.1016\/j.bpj.2013.07.011","journal-title":"Biophysical Journal"},{"issue":"7","key":"10367_CR34","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.21037\/tcr-2025-119","volume":"14","author":"J Liu","year":"2025","unstructured":"Liu, J., et al. (2025). IL-6 promotes metastasis and EMT of non-small cell lung cancer cells by up-regulating FGL1 via STAT3 pathway. Translational Cancer Research, 14(7), 3973\u20133990. https:\/\/doi.org\/10.21037\/tcr-2025-119","journal-title":"Translational Cancer Research"},{"key":"10367_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1195426","volume":"13","author":"C Wei","year":"2023","unstructured":"Wei, C. (2023). The multifaceted roles of matrix metalloproteinases in lung cancer. Frontiers in Oncology, 13, Article 1195426. https:\/\/doi.org\/10.3389\/fonc.2023.1195426","journal-title":"Frontiers in Oncology"},{"key":"10367_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.pharmthera.2018.09.007","volume":"194","author":"MK Jolly","year":"2019","unstructured":"Jolly, M. K., et al. (2019). Hybrid epithelial\/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas. Pharmacology & Therapeutics, 194, 161\u2013184. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.09.007","journal-title":"Pharmacology & Therapeutics"},{"issue":"3","key":"10367_CR37","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/onc.2013.560","volume":"34","author":"JP Webber","year":"2015","unstructured":"Webber, J. P., et al. (2015). Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. Oncogene, 34(3), 290\u2013302. https:\/\/doi.org\/10.1038\/onc.2013.560","journal-title":"Oncogene"},{"key":"10367_CR38","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1038\/ncomms7716","volume":"6","author":"N Tominaga","year":"2015","unstructured":"Tominaga, N., et al. (2015). Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nature Communications, 6, 6716. https:\/\/doi.org\/10.1038\/ncomms7716","journal-title":"Nature Communications"},{"key":"10367_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1015709","volume":"12","author":"X Zhao","year":"2022","unstructured":"Zhao, X., et al. (2022). Laminin-bound integrin \u03b16\u03b24 promotes non-small cell lung cancer progression via the activation of YAP\/TAZ signaling pathway. Frontiers in Oncology, 12, Article 1015709. https:\/\/doi.org\/10.3389\/fonc.2022.1015709","journal-title":"Frontiers in Oncology"},{"issue":"4","key":"10367_CR40","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","volume":"25","author":"W Zhou","year":"2014","unstructured":"Zhou, W., et al. (2014). Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell, 25(4), 501\u2013515. https:\/\/doi.org\/10.1016\/j.ccr.2014.03.007","journal-title":"Cancer Cell"},{"issue":"5867","key":"10367_CR41","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1126\/science.1153124","volume":"319","author":"K Trajkovic","year":"2008","unstructured":"Trajkovic, K., et al. (2008). Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science, 319(5867), 1244\u20131247. https:\/\/doi.org\/10.1126\/science.1153124","journal-title":"Science"},{"issue":"1","key":"10367_CR42","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/s41598-022-04940-6","volume":"12","author":"H Hasan","year":"2022","unstructured":"Hasan, H., et al. (2022). Extracellular vesicles released by non-small cell lung cancer cells drive invasion and permeability in non-tumorigenic lung epithelial cells. Scientific Reports, 12(1), 972. https:\/\/doi.org\/10.1038\/s41598-022-04940-6","journal-title":"Scientific Reports"},{"issue":"7069","key":"10367_CR43","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan, R. N., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438(7069), 820\u2013827. https:\/\/doi.org\/10.1038\/nature04186","journal-title":"Nature"},{"issue":"34","key":"10367_CR44","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1038\/onc.2017.105","volume":"36","author":"YL Hsu","year":"2017","unstructured":"Hsu, Y. L., et al. (2017). Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1. Oncogene, 36(34), 4929\u20134942. https:\/\/doi.org\/10.1038\/onc.2017.105","journal-title":"Oncogene"},{"issue":"9","key":"10367_CR45","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41419-021-04037-4","volume":"12","author":"Z Ma","year":"2021","unstructured":"Ma, Z., et al. (2021). Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP\/KLF2 in non-small cell lung cancer. Cell Death & Disease, 12(9), 840. https:\/\/doi.org\/10.1038\/s41419-021-04037-4","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10367_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12575-023-00192-4","volume":"25","author":"L Ye","year":"2023","unstructured":"Ye, L., et al. (2023). Influence of exosomes on astrocytes in the pre-metastatic niche of lung cancer brain metastases. Biological Procedures Online, 25(1), 5. https:\/\/doi.org\/10.1186\/s12575-023-00192-4","journal-title":"Biological Procedures Online"},{"issue":"12","key":"10367_CR47","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.21037\/tlcr-23-707","volume":"12","author":"X Feng","year":"2023","unstructured":"Feng, X., et al. (2023). Exosomal ITGB6 from dormant lung adenocarcinoma cells activates cancer-associated fibroblasts by KLF10 positive feedback loop and the TGF-\u03b2 pathway. Translational Lung Cancer Research, 12(12), 2520\u20132537. https:\/\/doi.org\/10.21037\/tlcr-23-707","journal-title":"Translational Lung Cancer Research"},{"issue":"6573","key":"10367_CR48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/380439a0","volume":"380","author":"N Ferrara","year":"1996","unstructured":"Ferrara, N., et al. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature, 380(6573), 439\u2013442. https:\/\/doi.org\/10.1038\/380439a0","journal-title":"Nature"},{"issue":"4","key":"10367_CR49","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/path.5152","volume":"246","author":"VL Thijssen","year":"2018","unstructured":"Thijssen, V. L., et al. (2018). Targeting PDGF-mediated recruitment of pericytes blocks vascular mimicry and tumor growth. The Journal of Pathology, 246(4), 447\u2013458. https:\/\/doi.org\/10.1002\/path.5152","journal-title":"The Journal of Pathology"},{"issue":"5","key":"10367_CR50","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ceb.2004.07.010","volume":"16","author":"JD Mott","year":"2004","unstructured":"Mott, J. D., & Werb, Z. (2004). Regulation of matrix biology by matrix metalloproteinases. Current Opinion in Cell Biology, 16(5), 558\u2013564. https:\/\/doi.org\/10.1016\/j.ceb.2004.07.010","journal-title":"Current Opinion in Cell Biology"},{"key":"10367_CR51","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.3627","volume":"5","author":"Y Zheng","year":"2017","unstructured":"Zheng, Y., et al. (2017). The extracellular vesicles secreted by lung cancer cells in radiation therapy promote endothelial cell angiogenesis by transferring miR-23a. PeerJ, 5, Article e3627. https:\/\/doi.org\/10.7717\/peerj.3627","journal-title":"PeerJ"},{"key":"10367_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00326","volume":"10","author":"J Du","year":"2020","unstructured":"Du, J., et al. (2020). Gastric cancer cell-derived exosomal microRNA-23a promotes angiogenesis by targeting PTEN. Frontiers in Oncology, 10, Article 326. https:\/\/doi.org\/10.3389\/fonc.2020.00326","journal-title":"Frontiers in Oncology"},{"key":"10367_CR53","doi-asserted-by":"publisher","first-page":"tkae071","DOI":"10.1093\/burnst\/tkae071","volume":"13","author":"Y Chen","year":"2025","unstructured":"Chen, Y., et al. (2025). Exosomes derived from fibroblasts enhance skin wound angiogenesis by regulating HIF-1\u03b1\/VEGF\/VEGFR pathway. Burns Trauma, 13, tkae071. https:\/\/doi.org\/10.1093\/burnst\/tkae071","journal-title":"Burns Trauma"},{"issue":"1","key":"10367_CR54","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12935-024-03519-7","volume":"24","author":"Y Ning","year":"2024","unstructured":"Ning, Y., et al. (2024). RhoA-ROCK2 signaling possesses complex pathophysiological functions in cancer progression and shows promising therapeutic potential. Cancer Cell International, 24(1), 339. https:\/\/doi.org\/10.1186\/s12935-024-03519-7","journal-title":"Cancer Cell International"},{"issue":"2","key":"10367_CR55","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cell.2017.06.031","volume":"170","author":"BY Nabet","year":"2017","unstructured":"Nabet, B. Y., et al. (2017). Exosome RNA unshielding couples stromal activation to pattern recognition receptor signaling in cancer. Cell, 170(2), 352-366.e13. https:\/\/doi.org\/10.1016\/j.cell.2017.06.031","journal-title":"Cell"},{"issue":"5","key":"10367_CR56","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1158\/2767-9764.Crc-23-0431","volume":"4","author":"A Sneider","year":"2024","unstructured":"Sneider, A., et al. (2024). Small extracellular vesicles promote stiffness-mediated metastasis. Cancer Research Communications,4(5), 1240\u20131252. https:\/\/doi.org\/10.1158\/2767-9764.Crc-23-0431","journal-title":"Cancer Research Communications"},{"issue":"1","key":"10367_CR57","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/1878-0261.12837","volume":"15","author":"WF Wei","year":"2021","unstructured":"Wei, W. F., et al. (2021). Periostin(+) cancer-associated fibroblasts promote lymph node metastasis by impairing the lymphatic endothelial barriers in cervical squamous cell carcinoma. Molecular Oncology, 15(1), 210\u2013227. https:\/\/doi.org\/10.1002\/1878-0261.12837","journal-title":"Molecular Oncology"},{"issue":"7","key":"10367_CR58","doi-asserted-by":"publisher","DOI":"10.1088\/1367-2630\/ade81e","volume":"27","author":"T Zhang","year":"2025","unstructured":"Zhang, T., et al. (2025). Enhanced extracellular matrix remodeling due to embedded spheroid fluidization. New Journal of Physics, 27(7), Article 073301. https:\/\/doi.org\/10.1088\/1367-2630\/ade81e","journal-title":"New Journal of Physics"},{"issue":"7693","key":"10367_CR59","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan, S., et al. (2018). TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature, 554(7693), 544\u2013548. https:\/\/doi.org\/10.1038\/nature25501","journal-title":"Nature"},{"issue":"1","key":"10367_CR60","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.1038\/s41467-020-18298-8","volume":"11","author":"DH Peng","year":"2020","unstructured":"Peng, D. H., et al. (2020). Collagen promotes anti-PD-1\/PD-L1 resistance in cancer through LAIR1-dependent CD8(+) T cell exhaustion. Nature Communications, 11(1), 4520. https:\/\/doi.org\/10.1038\/s41467-020-18298-8","journal-title":"Nature Communications"},{"issue":"3","key":"10367_CR61","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1172\/jci45817","volume":"122","author":"H Salmon","year":"2012","unstructured":"Salmon, H., et al. (2012). Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. Journal of Clinical Investigation, 122(3), 899\u2013910. https:\/\/doi.org\/10.1172\/jci45817","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10367_CR62","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2016.12.005","volume":"31","author":"G Mollaoglu","year":"2017","unstructured":"Mollaoglu, G., et al. (2017). MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to Aurora kinase inhibition. Cancer Cell, 31(2), 270\u2013285. https:\/\/doi.org\/10.1016\/j.ccell.2016.12.005","journal-title":"Cancer Cell"},{"issue":"3","key":"10367_CR63","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","volume":"39","author":"CM Gay","year":"2021","unstructured":"Gay, C. M., et al. (2021). Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell, 39(3), 346-360.e7. https:\/\/doi.org\/10.1016\/j.ccell.2020.12.014","journal-title":"Cancer Cell"},{"issue":"4","key":"10367_CR64","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1164\/rccm.201406-1137OC","volume":"191","author":"A Schmall","year":"2015","unstructured":"Schmall, A., et al. (2015). Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer. American Journal of Respiratory and Critical Care Medicine, 191(4), 437\u2013447. https:\/\/doi.org\/10.1164\/rccm.201406-1137OC","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"10","key":"10367_CR65","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1084\/jem.20011624","volume":"195","author":"G Andreola","year":"2002","unstructured":"Andreola, G., et al. (2002). Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. Journal of Experimental Medicine, 195(10), 1303\u20131316. https:\/\/doi.org\/10.1084\/jem.20011624","journal-title":"Journal of Experimental Medicine"},{"issue":"1","key":"10367_CR66","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41467-018-03224-w","volume":"9","author":"T Cooks","year":"2018","unstructured":"Cooks, T., et al. (2018). Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246. Nature Communications, 9(1), 771. https:\/\/doi.org\/10.1038\/s41467-018-03224-w","journal-title":"Nature Communications"},{"issue":"33","key":"10367_CR67","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov, K. D., et al. (2006). NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A, 103(33), 12481\u201312486. https:\/\/doi.org\/10.1073\/pnas.0605298103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10367_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.679658","volume":"9","author":"J Liu","year":"2021","unstructured":"Liu, J., et al. (2021). Tumor cell-derived exosomal miR-770 inhibits M2 macrophage polarization via targeting MAP3K1 to inhibit the invasion of non-small cell lung cancer cells. Frontiers in Cell and Developmental Biology, 9, Article 679658. https:\/\/doi.org\/10.3389\/fcell.2021.679658","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"20","key":"10367_CR69","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.15252\/embj.201696003","volume":"36","author":"M Tkach","year":"2017","unstructured":"Tkach, M., et al. (2017). Qualitative differences in T-cell activation by dendritic cell-derived extracellular vesicle subtypes. The EMBO Journal, 36(20), 3012\u20133028. https:\/\/doi.org\/10.15252\/embj.201696003","journal-title":"The EMBO Journal"},{"issue":"6","key":"10367_CR70","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s1471-4906(02)02233-0","volume":"23","author":"M Triantafilou","year":"2002","unstructured":"Triantafilou, M., & Triantafilou, K. (2002). Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends in Immunology, 23(6), 301\u2013304. https:\/\/doi.org\/10.1016\/s1471-4906(02)02233-0","journal-title":"Trends in Immunology"},{"issue":"11","key":"10367_CR71","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.4049\/jimmunol.180.11.7249","volume":"180","author":"A Clayton","year":"2008","unstructured":"Clayton, A., et al. (2008). Human tumor-derived exosomes down-modulate NKG2D expression. Journal of Immunology, 180(11), 7249\u20137258. https:\/\/doi.org\/10.4049\/jimmunol.180.11.7249","journal-title":"Journal of Immunology"},{"issue":"1","key":"10367_CR72","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12964-025-02619-9","volume":"24","author":"Q Li","year":"2026","unstructured":"Li, Q., et al. (2026). PD-L1 deficient exosomes derived from lung cancer cell line enhances NK cell-mediated anti-tumor immunity against lung cancer. Cell Communication and Signaling,24(1), 74. https:\/\/doi.org\/10.1186\/s12964-025-02619-9","journal-title":"Cell Communication and Signaling"},{"key":"10367_CR73","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.imlet.2018.05.002","volume":"199","author":"Y Ning","year":"2018","unstructured":"Ning, Y., et al. (2018). Tumor exosomes block dendritic cells maturation to decrease the T cell immune response. Immunology Letters, 199, 36\u201343. https:\/\/doi.org\/10.1016\/j.imlet.2018.05.002","journal-title":"Immunology Letters"},{"issue":"3","key":"10367_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004942","volume":"4","author":"S Viaud","year":"2009","unstructured":"Viaud, S., et al. (2009). Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: A role for NKG2D ligands and IL-15Ralpha. PLoS ONE, 4(3), Article e4942. https:\/\/doi.org\/10.1371\/journal.pone.0004942","journal-title":"PLoS ONE"},{"issue":"1","key":"10367_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-3-9","volume":"3","author":"MA Morse","year":"2005","unstructured":"Morse, M. A., et al. (2005). A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. Journal of Translational Medicine, 3(1), Article 9. https:\/\/doi.org\/10.1186\/1479-5876-3-9","journal-title":"Journal of Translational Medicine"},{"issue":"4","key":"10367_CR76","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2015.1071008","volume":"5","author":"B Besse","year":"2016","unstructured":"Besse, B., et al. (2016). Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. OncoImmunology, 5(4), Article e1071008. https:\/\/doi.org\/10.1080\/2162402x.2015.1071008","journal-title":"OncoImmunology"},{"issue":"2","key":"10367_CR77","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/JTO.0b013e3182398e69","volume":"7","author":"T Yamada","year":"2012","unstructured":"Yamada, T., et al. (2012). Hepatocyte growth factor induces resistance to anti-epidermal growth factor receptor antibody in lung cancer. Journal of Thoracic Oncology,7(2), 272\u2013280. https:\/\/doi.org\/10.1097\/JTO.0b013e3182398e69","journal-title":"Journal of Thoracic Oncology"},{"issue":"5","key":"10367_CR78","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura, D., et al. (2018). Enhancing cancer immunotherapy using antiangiogenics: Opportunities and challenges. Nature Reviews Clinical Oncology, 15(5), 325\u2013340. https:\/\/doi.org\/10.1038\/nrclinonc.2018.29","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"11","key":"10367_CR79","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1158\/2159-8290.Cd-24-1515","volume":"15","author":"S Baldacci","year":"2025","unstructured":"Baldacci, S., et al. (2025). Eradicating drug-tolerant persister cells in EGFR-mutated non-small cell lung cancer by targeting TROP2 with CAR-T cellular therapy. Cancer Discovery, 15(11), 2235\u20132250. https:\/\/doi.org\/10.1158\/2159-8290.Cd-24-1515","journal-title":"Cancer Discovery"},{"key":"10367_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2021.631969","volume":"27","author":"R Puskas","year":"2021","unstructured":"Puskas, R., et al. (2021). Circulating survivin protein levels in lung cancer patients treated with platinum-based chemotherapy. Pathology & Oncology Research, 27, Article 631969. https:\/\/doi.org\/10.3389\/pore.2021.631969","journal-title":"Pathology & Oncology Research"},{"key":"10367_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.724389","volume":"9","author":"E Purcell","year":"2021","unstructured":"Purcell, E., et al. (2021). Epidermal growth factor receptor mutations carried in extracellular vesicle-derived cargo mirror disease status in metastatic non-small cell lung cancer. Frontiers in Cell and Developmental Biology, 9, Article 724389. https:\/\/doi.org\/10.3389\/fcell.2021.724389","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10367_CR82","doi-asserted-by":"publisher","unstructured":"Gong, X., Zhou, Y., & Deng, Y. (2025). Targeting DNA damage response-mediated resistance in non-small cell lung cancer: From mechanistic insights to drug development. Current Oncology, 32(7). https:\/\/doi.org\/10.3390\/curroncol32070367","DOI":"10.3390\/curroncol32070367"},{"key":"10367_CR83","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.2147\/ott.S186922","volume":"12","author":"C Dong","year":"2019","unstructured":"Dong, C., et al. (2019). Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin. OncoTargets and Therapy, 12, 1947\u20131956. https:\/\/doi.org\/10.2147\/ott.S186922","journal-title":"OncoTargets and Therapy"},{"issue":"1","key":"10367_CR84","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12943-021-01307-9","volume":"20","author":"S Wu","year":"2021","unstructured":"Wu, S., et al. (2021). Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer. Molecular Cancer, 20(1), 17. https:\/\/doi.org\/10.1186\/s12943-021-01307-9","journal-title":"Molecular Cancer"},{"key":"10367_CR85","doi-asserted-by":"publisher","DOI":"10.1177\/1559325820926744","author":"S Pan","year":"2020","unstructured":"Pan, S., et al. (2020). Radiation exposure-induced changes in the immune cells and immune factors of mice with or without primary lung tumor. Dose-Response. https:\/\/doi.org\/10.1177\/1559325820926744","journal-title":"Dose-Response"},{"issue":"6","key":"10367_CR86","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41419-018-0626-6","volume":"9","author":"S He","year":"2018","unstructured":"He, S., et al. (2018). HMGB1 released by irradiated tumor cells promotes living tumor cell proliferation via paracrine effect. Cell Death & Disease, 9(6), 648. https:\/\/doi.org\/10.1038\/s41419-018-0626-6","journal-title":"Cell Death & Disease"},{"issue":"42","key":"10367_CR87","doi-asserted-by":"publisher","first-page":"16975","DOI":"10.1073\/pnas.1315862110","volume":"110","author":"Y Wang","year":"2013","unstructured":"Wang, Y., et al. (2013). STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor. Proceedings of the National Academy of Sciences of the United States of America, 110(42), 16975\u201316980. https:\/\/doi.org\/10.1073\/pnas.1315862110","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"10367_CR88","first-page":"4278","volume":"61","author":"AK Gupta","year":"2001","unstructured":"Gupta, A. K., et al. (2001). The Ras radiation resistance pathway. Cancer Research,61(10), 4278\u20134282.","journal-title":"Cancer Research"},{"issue":"11","key":"10367_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202300030","volume":"24","author":"L Jimenez","year":"2024","unstructured":"Jimenez, L., et al. (2024). Extracellular vesicles from non-neuroendocrine SCLC cells promote adhesion and survival of neuroendocrine SCLC cells. Proteomics, 24(11), Article e2300030. https:\/\/doi.org\/10.1002\/pmic.202300030","journal-title":"Proteomics"},{"issue":"1","key":"10367_CR90","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1038\/s41598-024-52687-z","volume":"14","author":"Y Lu","year":"2024","unstructured":"Lu, Y., et al. (2024). Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer. Science and Reports, 14(1), 2884. https:\/\/doi.org\/10.1038\/s41598-024-52687-z","journal-title":"Science and Reports"},{"issue":"3","key":"10367_CR91","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1165\/rcmb.2018-0062OC","volume":"60","author":"D Chanda","year":"2019","unstructured":"Chanda, D., et al. (2019). Fibronectin on the surface of extracellular vesicles mediates fibroblast invasion. American Journal of Respiratory Cell and Molecular Biology, 60(3), 279\u2013288. https:\/\/doi.org\/10.1165\/rcmb.2018-0062OC","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"1","key":"10367_CR92","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry, C., et al. (2018). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles, 7(1), Article 1535750. https:\/\/doi.org\/10.1080\/20013078.2018.1535750","journal-title":"J Extracell Vesicles"},{"key":"10367_CR93","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3.24858","author":"J Van Deun","year":"2014","unstructured":"Van Deun, J., et al. (2014). The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. Journal of Extracellular Vesicles. https:\/\/doi.org\/10.3402\/jev.v3.24858","journal-title":"Journal of Extracellular Vesicles"},{"issue":"3","key":"10367_CR94","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nprot.2008.226","volume":"4","author":"J Friedrich","year":"2009","unstructured":"Friedrich, J., et al. (2009). Spheroid-based drug screen: Considerations and practical approach. Nature Protocols, 4(3), 309\u2013324. https:\/\/doi.org\/10.1038\/nprot.2008.226","journal-title":"Nature Protocols"},{"key":"10367_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/srep19103","volume":"6","author":"M Zanoni","year":"2016","unstructured":"Zanoni, M., et al. (2016). 3D tumor spheroid models for in vitro therapeutic screening: A systematic approach to enhance the biological relevance of data obtained. Science and Reports, 6, Article 19103. https:\/\/doi.org\/10.1038\/srep19103","journal-title":"Science and Reports"},{"issue":"6","key":"10367_CR96","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"174","author":"KK Dijkstra","year":"2018","unstructured":"Dijkstra, K. K., et al. (2018). Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell, 174(6), 1586-1598.e12. https:\/\/doi.org\/10.1016\/j.cell.2018.07.009","journal-title":"Cell"},{"key":"10367_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-10-29","volume":"10","author":"M Vinci","year":"2012","unstructured":"Vinci, M., et al. (2012). Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biology, 10, Article 29. https:\/\/doi.org\/10.1186\/1741-7007-10-29","journal-title":"BMC Biology"},{"key":"10367_CR98","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.reth.2025.04.005","volume":"29","author":"N Singh","year":"2025","unstructured":"Singh, N., Choonara, Y. E., & Kumar, P. (2025). Method standardization of secretome production, collection, and characterization: New insights and challenges. Regenerative Therapy, 29, 466\u2013473. https:\/\/doi.org\/10.1016\/j.reth.2025.04.005","journal-title":"Regenerative Therapy"},{"key":"10367_CR99","doi-asserted-by":"publisher","unstructured":"Crescitelli, R., et al. (2013). Distinct RNA profiles in subpopulations of extracellular vesicles: Apoptotic bodies, microvesicles and exosomes. Journal of Extracellular Vesicles, 2. https:\/\/doi.org\/10.3402\/jev.v2i0.20677","DOI":"10.3402\/jev.v2i0.20677"},{"key":"10367_CR100","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bbacli.2017.03.001","volume":"7","author":"A Hmmier","year":"2017","unstructured":"Hmmier, A., et al. (2017). Proteomic analysis of bronchoalveolar lavage fluid (BALF) from lung cancer patients using label-free mass spectrometry. BBA Clin, 7, 97\u2013104. https:\/\/doi.org\/10.1016\/j.bbacli.2017.03.001","journal-title":"BBA Clin"},{"key":"10367_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/srep42190","volume":"7","author":"AS Carvalho","year":"2017","unstructured":"Carvalho, A. S., et al. (2017). Bronchoalveolar lavage proteomics in patients with suspected lung cancer. Scientific Reports, 7, Article 42190. https:\/\/doi.org\/10.1038\/srep42190","journal-title":"Scientific Reports"},{"issue":"2","key":"10367_CR102","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A., et al. (2024). Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. Journal of Extracellular Vesicles, 13(2), Article e12404. https:\/\/doi.org\/10.1002\/jev2.12404","journal-title":"Journal of Extracellular Vesicles"},{"issue":"12","key":"10367_CR103","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12385","volume":"12","author":"F Lucien","year":"2023","unstructured":"Lucien, F., et al. (2023). MIBlood-EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research. Journal of Extracellular Vesicles, 12(12), Article e12385. https:\/\/doi.org\/10.1002\/jev2.12385","journal-title":"Journal of Extracellular Vesicles"},{"issue":"1","key":"10367_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12400","volume":"13","author":"R Nieuwland","year":"2024","unstructured":"Nieuwland, R., & Siljander, P. R. (2024). A beginner\u2019s guide to study extracellular vesicles in human blood plasma and serum. Journal of Extracellular Vesicles, 13(1), Article e12400. https:\/\/doi.org\/10.1002\/jev2.12400","journal-title":"Journal of Extracellular Vesicles"},{"issue":"1","key":"10367_CR105","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2020.1713526","volume":"9","author":"JA Welsh","year":"2020","unstructured":"Welsh, J. A., et al. (2020). MIFlowCyt-EV: A framework for standardized reporting of extracellular vesicle flow cytometry experiments. Journal of Extracell Vesicles, 9(1), Article 1713526. https:\/\/doi.org\/10.1080\/20013078.2020.1713526","journal-title":"Journal of Extracell Vesicles"},{"key":"10367_CR106","doi-asserted-by":"publisher","unstructured":"Ter-Ovanesyan, D., et al., (2023). Improved isolation of extracellular vesicles by removal of both free proteins and lipoproteins. Elife, 12.https:\/\/doi.org\/10.7554\/eLife.86394","DOI":"10.7554\/eLife.86394"},{"key":"10367_CR107","doi-asserted-by":"publisher","unstructured":"Benayas, B., et al., (2025). Optimized size exclusion chromatography demonstrates that extracellular vesicles are the key RNA carriers of ALK translocations in non-small cell lung cancer cell line secretome and patient plasma. Extracellular Vesicles and Circulating Nucleic Acids, 6(2), 310. https:\/\/doi.org\/10.20517\/evcna.2025.14","DOI":"10.20517\/evcna.2025.14"},{"key":"10367_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174121","author":"Y Cui","year":"2022","unstructured":"Cui, Y., et al. (2022). Dynamic expression of EpCAM in primary and metastatic lung cancer is controlled by both genetic and epigenetic mechanisms. Cancers. https:\/\/doi.org\/10.3390\/cancers14174121","journal-title":"Cancers"},{"key":"10367_CR109","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2147\/cmar.S449777","volume":"16","author":"Y Huangfu","year":"2024","unstructured":"Huangfu, Y., et al. (2024). Linking EMT status of circulating tumor cells to clinical outcomes in lung cancer. Cancer Management and Research, 16, 325\u2013336. https:\/\/doi.org\/10.2147\/cmar.S449777","journal-title":"Cancer Management and Research"},{"issue":"2","key":"10367_CR110","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/JTO.0b013e31823c5c16","volume":"7","author":"MG Krebs","year":"2012","unstructured":"Krebs, M. G., et al. (2012). Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. Journal of Thoracic Oncology, 7(2), 306\u2013315. https:\/\/doi.org\/10.1097\/JTO.0b013e31823c5c16","journal-title":"Journal of Thoracic Oncology"},{"issue":"9","key":"10367_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100830","volume":"23","author":"VM Beutgen","year":"2024","unstructured":"Beutgen, V. M., et al. (2024). Secretome analysis using affinity proteomics and immunoassays: A focus on tumor biology. Molecular & Cellular Proteomics, 23(9), Article 100830. https:\/\/doi.org\/10.1016\/j.mcpro.2024.100830","journal-title":"Molecular & Cellular Proteomics"},{"issue":"3","key":"10367_CR112","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cels.2016.02.015","volume":"2","author":"PE Geyer","year":"2016","unstructured":"Geyer, P. E., et al. (2016). Plasma proteome profiling to assess human health and disease. Cell Systems, 2(3), 185\u2013195. https:\/\/doi.org\/10.1016\/j.cels.2016.02.015","journal-title":"Cell Systems"},{"issue":"1","key":"10367_CR113","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41467-017-00249-5","volume":"8","author":"BC Collins","year":"2017","unstructured":"Collins, B. C., et al. (2017). Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry. Nature Communications, 8(1), 291. https:\/\/doi.org\/10.1038\/s41467-017-00249-5","journal-title":"Nature Communications"},{"issue":"12","key":"10367_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70024","volume":"13","author":"X Su","year":"2024","unstructured":"Su, X., et al. (2024). Enhanced proteomic profiling of human plasma-derived extracellular vesicles through charge-based fractionation to advance biomarker discovery potential. Journal of Extracellular Vesicles, 13(12), Article e70024. https:\/\/doi.org\/10.1002\/jev2.70024","journal-title":"Journal of Extracellular Vesicles"},{"issue":"6","key":"10367_CR115","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1021\/acs.jproteome.5c00221","volume":"24","author":"WF Beimers","year":"2025","unstructured":"Beimers, W. F., et al. (2025). Technical evaluation of plasma proteomics technologies. Journal of Proteome Research, 24(6), 3074\u20133087. https:\/\/doi.org\/10.1021\/acs.jproteome.5c00221","journal-title":"Journal of Proteome Research"},{"issue":"7","key":"10367_CR116","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/nprot.2017.040","volume":"12","author":"OT Schubert","year":"2017","unstructured":"Schubert, O. T., et al. (2017). Quantitative proteomics: Challenges and opportunities in basic and applied research. Nature Protocols, 12(7), 1289\u20131294. https:\/\/doi.org\/10.1038\/nprot.2017.040","journal-title":"Nature Protocols"},{"issue":"1","key":"10367_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92012-6","volume":"11","author":"L Sun","year":"2021","unstructured":"Sun, L., & Meckes, D. G., Jr. (2021). Multiplex protein profiling method for extracellular vesicle protein detection. Scientific Reports, 11(1), Article 12477. https:\/\/doi.org\/10.1038\/s41598-021-92012-6","journal-title":"Scientific Reports"},{"issue":"4","key":"10367_CR118","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ncb2210","volume":"13","author":"KC Vickers","year":"2011","unstructured":"Vickers, K. C., et al. (2011). MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature Cell Biology, 13(4), 423\u2013433. https:\/\/doi.org\/10.1038\/ncb2210","journal-title":"Nature Cell Biology"},{"issue":"1","key":"10367_CR119","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41596-019-0236-5","volume":"15","author":"J Tulkens","year":"2020","unstructured":"Tulkens, J., De Wever, O., & Hendrix, A. (2020). Analyzing bacterial extracellular vesicles in human body fluids by orthogonal biophysical separation and biochemical characterization. Nature Protocols, 15(1), 40\u201367. https:\/\/doi.org\/10.1038\/s41596-019-0236-5","journal-title":"Nature Protocols"},{"issue":"2","key":"10367_CR120","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/cas.15222","volume":"113","author":"S Gao","year":"2022","unstructured":"Gao, S., et al. (2022). Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma. Cancer Science, 113(2), 648\u2013659. https:\/\/doi.org\/10.1111\/cas.15222","journal-title":"Cancer Science"},{"issue":"7","key":"10367_CR121","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/ijc.34386","volume":"152","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., et al. (2023). Extracellular vesicle long RNA markers of early-stage lung adenocarcinoma. International Journal of Cancer, 152(7), 1490\u20131500. https:\/\/doi.org\/10.1002\/ijc.34386","journal-title":"International Journal of Cancer"},{"issue":"11","key":"10367_CR122","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.21873\/anticanres.17299","volume":"44","author":"S Naser","year":"2024","unstructured":"Naser, S., et al. (2024). Metabolomic profiling of large extracellular vesicles in patients suffering from small cell lung cancer. Anticancer Research, 44(11), 4729\u20134735. https:\/\/doi.org\/10.21873\/anticanres.17299","journal-title":"Anticancer Research"},{"key":"10367_CR123","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6209865","author":"MT Zeuner","year":"2017","unstructured":"Zeuner, M. T., et al. (2017). Development and characterisation of a novel NF-\u03baB reporter cell line for investigation of neuroinflammation. Mediators of Inflammation. https:\/\/doi.org\/10.1155\/2017\/6209865","journal-title":"Mediators of Inflammation"},{"key":"10367_CR124","doi-asserted-by":"publisher","unstructured":"Mulcahy, L. A., Pink, R. C., & Carterm D. R. (2014). Routes and mechanisms of extracellular vesicle uptake. Journal of Extracellular Vesicles, 3. https:\/\/doi.org\/10.3402\/jev.v3.24641","DOI":"10.3402\/jev.v3.24641"},{"key":"10367_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/biology14111578","author":"D Mannaperuma","year":"2025","unstructured":"Mannaperuma, D., et al. (2025). Extracellular vesicles from the myocyte secretome contribute in vitro to creating an unfavourable environment for migrating lung carcinoma cells. Biology. https:\/\/doi.org\/10.3390\/biology14111578","journal-title":"Biology"},{"issue":"9","key":"10367_CR126","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/JTO.0b013e318299ac32","volume":"8","author":"R Cazzoli","year":"2013","unstructured":"Cazzoli, R., et al. (2013). microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. Journal of Thoracic Oncology, 8(9), 1156\u20131162. https:\/\/doi.org\/10.1097\/JTO.0b013e318299ac32","journal-title":"Journal of Thoracic Oncology"},{"issue":"3","key":"10367_CR127","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/annonc\/mdx765","volume":"29","author":"AK Krug","year":"2018","unstructured":"Krug, A. K., et al. (2018). Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma. Annals of Oncology, 29(3), 700\u2013706. https:\/\/doi.org\/10.1093\/annonc\/mdx765","journal-title":"Annals of Oncology"},{"key":"10367_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/life14121608","author":"I Mart\u00ednez-Espinosa","year":"2024","unstructured":"Mart\u00ednez-Espinosa, I., et al. (2024). Exosome-derived miRNAs in liquid biopsy for lung cancer. Life. https:\/\/doi.org\/10.3390\/life14121608","journal-title":"Life"},{"key":"10367_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00197","volume":"9","author":"Y Yang","year":"2019","unstructured":"Yang, Y., et al. (2019). Bronchoalveolar lavage fluid-derived exosomes: A novel role contributing to lung cancer growth. Frontiers in Oncology, 9, Article 197. https:\/\/doi.org\/10.3389\/fonc.2019.00197","journal-title":"Frontiers in Oncology"},{"issue":"3","key":"10367_CR130","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4161\/rna.8.3.14994","volume":"8","author":"A Keller","year":"2011","unstructured":"Keller, A., et al. (2011). Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biology, 8(3), 506\u2013516. https:\/\/doi.org\/10.4161\/rna.8.3.14994","journal-title":"RNA Biology"},{"issue":"4","key":"10367_CR131","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/jto.0000000000000447","volume":"10","author":"A Vachani","year":"2015","unstructured":"Vachani, A., et al. (2015). Validation of a multiprotein plasma classifier to identify benign lung nodules. Journal of Thoracic Oncology, 10(4), 629\u2013637. https:\/\/doi.org\/10.1097\/jto.0000000000000447","journal-title":"Journal of Thoracic Oncology"},{"issue":"1","key":"10367_CR132","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2017.1286095","volume":"6","author":"B Mateescu","year":"2017","unstructured":"Mateescu, B., et al. (2017). Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - An ISEV position paper. Journal of Extracellular Vesicles, 6(1), Article 1286095. https:\/\/doi.org\/10.1080\/20013078.2017.1286095","journal-title":"Journal of Extracellular Vesicles"},{"issue":"14","key":"10367_CR133","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12182","volume":"10","author":"KW Witwer","year":"2021","unstructured":"Witwer, K. W., et al. (2021). Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles. Journal of Extracellular Vesicles, 10(14), Article e12182. https:\/\/doi.org\/10.1002\/jev2.12182","journal-title":"Journal of Extracellular Vesicles"},{"issue":"16","key":"10367_CR134","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1158\/0008-5472.Can-22-0554","volume":"82","author":"VS Nair","year":"2022","unstructured":"Nair, V. S., et al. (2022). Genomic profiling of bronchoalveolar lavage fluid in lung cancer. Cancer Research, 82(16), 2838\u20132847. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-0554","journal-title":"Cancer Research"},{"issue":"4","key":"10367_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12440","volume":"13","author":"MI Mitchell","year":"2024","unstructured":"Mitchell, M. I., et al. (2024). Exhaled breath condensate contains extracellular vesicles (EVs) that carry miRNA cargos of lung tissue origin that can be selectively purified and analyzed. Journal of Extracellular Vesicles, 13(4), Article e12440. https:\/\/doi.org\/10.1002\/jev2.12440","journal-title":"Journal of Extracellular Vesicles"},{"issue":"2","key":"10367_CR136","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00204-024-03915-y","volume":"99","author":"S McCarrick","year":"2025","unstructured":"McCarrick, S., et al. (2025). Pulmonary exposure to renewable diesel exhaust particles alters protein expression and toxicity profiles in bronchoalveolar lavage fluid and plasma of mice. Archives of Toxicology, 99(2), 797\u2013814. https:\/\/doi.org\/10.1007\/s00204-024-03915-y","journal-title":"Archives of Toxicology"},{"issue":"1","key":"10367_CR137","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12931-025-03330-6","volume":"26","author":"J Fang","year":"2025","unstructured":"Fang, J., et al. (2025). Extracellular vesicles from bronchoalveolar lavage fluid provide insights into the inhaled corticosteroids treatment response in COPD. Respiratory Research, 26(1), 254. https:\/\/doi.org\/10.1186\/s12931-025-03330-6","journal-title":"Respiratory Research"},{"issue":"2","key":"10367_CR138","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","volume":"177","author":"DK Jeppesen","year":"2019","unstructured":"Jeppesen, D. K., et al. (2019). Reassessment of exosome composition. Cell, 177(2), 428-445.e18. https:\/\/doi.org\/10.1016\/j.cell.2019.02.029","journal-title":"Cell"},{"issue":"9","key":"10367_CR139","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1002\/1878-0261.12889","volume":"15","author":"Y Zhong","year":"2021","unstructured":"Zhong, Y., et al. (2021). Discovery and validation of extracellular vesicle-associated miRNAs as noninvasive detection biomarkers for early-stage non-small-cell lung cancer. Molecular Oncology, 15(9), 2439\u20132452. https:\/\/doi.org\/10.1002\/1878-0261.12889","journal-title":"Molecular Oncology"},{"issue":"10","key":"10367_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21059","volume":"9","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q., et al. (2023). Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer. Heliyon, 9(10), Article e21059. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21059","journal-title":"Heliyon"},{"issue":"1","key":"10367_CR141","doi-asserted-by":"publisher","first-page":"17201","DOI":"10.1038\/s41598-022-22194-0","volume":"12","author":"YF Jiang","year":"2022","unstructured":"Jiang, Y. F., et al. (2022). Evaluation of circulating small extracellular vesicle-derived miRNAs as diagnostic biomarkers for differentiating between different pathological types of early lung cancer. Science and Reports, 12(1), 17201. https:\/\/doi.org\/10.1038\/s41598-022-22194-0","journal-title":"Science and Reports"},{"issue":"15","key":"10367_CR142","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.7150\/jca.30425","volume":"10","author":"F Wu","year":"2019","unstructured":"Wu, F., et al. (2019). Smoking induced extracellular vesicles release and their distinct properties in non-small cell lung cancer. Journal of Cancer, 10(15), 3435\u20133443. https:\/\/doi.org\/10.7150\/jca.30425","journal-title":"Journal of Cancer"},{"key":"10367_CR143","doi-asserted-by":"publisher","unstructured":"Cha, S., et al. (2026). Integration of circulating tumor DNA data enhances lung cancer prediction in patients with COPD. Scientific Reports, 16(1). https:\/\/doi.org\/10.1038\/s41598-026-41720-y","DOI":"10.1038\/s41598-026-41720-y"},{"issue":"1","key":"10367_CR144","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s12672-025-02434-1","volume":"16","author":"T Ding","year":"2025","unstructured":"Ding, T., Lin, Q., & Qu, X. (2025). From chronic obstructive pulmonary disease (COPD) to lung cancer: A Mendelian randomization study revealing mediation pathways through plasma metabolomics, proteomics, and immunophenotyping. Discovery Oncology, 16(1), 629. https:\/\/doi.org\/10.1007\/s12672-025-02434-1","journal-title":"Discovery Oncology"},{"issue":"1","key":"10367_CR145","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12575-023-00223-0","volume":"25","author":"B Luo","year":"2023","unstructured":"Luo, B., et al. (2023). Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer. Biological Procedures Online, 25(1), 29. https:\/\/doi.org\/10.1186\/s12575-023-00223-0","journal-title":"Biological Procedures Online"},{"key":"10367_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15212735","author":"YJ Kim","year":"2025","unstructured":"Kim, Y. J., et al. (2025). Exosomal microRNA panels for detecting early-stage non-small cell lung cancer. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics15212735","journal-title":"Diagnostics"},{"issue":"6","key":"10367_CR147","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1056\/NEJMe1916361","volume":"382","author":"SW Duffy","year":"2020","unstructured":"Duffy, S. W., & Field, J. K. (2020). mortality reduction with low-dose CT screening for lung cancer. New England Journal of Medicine, 382(6), 572\u2013573. https:\/\/doi.org\/10.1056\/NEJMe1916361","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10367_CR148","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"DR Aberle","year":"2011","unstructured":"Aberle, D. R., et al. (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. New England Journal of Medicine, 365(5), 395\u2013409. https:\/\/doi.org\/10.1056\/NEJMoa1102873","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10367_CR149","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41467-023-36932-z","volume":"14","author":"JD Spitzberg","year":"2023","unstructured":"Spitzberg, J. D., et al. (2023). Multiplexed analysis of EV reveals specific biomarker composition with diagnostic impact. Nature Communications, 14(1), 1239. https:\/\/doi.org\/10.1038\/s41467-023-36932-z","journal-title":"Nature Communications"},{"issue":"1","key":"10367_CR150","doi-asserted-by":"publisher","first-page":"8271","DOI":"10.1038\/s41598-020-65207-6","volume":"10","author":"LH Sun","year":"2020","unstructured":"Sun, L. H., et al. (2020). Exosomal miR-21 promotes proliferation, invasion and therapy resistance of colon adenocarcinoma cells through its target PDCD4. Science and Reports, 10(1), 8271. https:\/\/doi.org\/10.1038\/s41598-020-65207-6","journal-title":"Science and Reports"},{"issue":"6","key":"10367_CR151","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/bjc.2018.9","volume":"118","author":"M Del Re","year":"2018","unstructured":"Del Re, M., et al. (2018). PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC. British Journal of Cancer, 118(6), 820\u2013824. https:\/\/doi.org\/10.1038\/bjc.2018.9","journal-title":"British Journal of Cancer"},{"key":"10367_CR152","doi-asserted-by":"publisher","unstructured":"Kim, I. A., et al. (2022). Extracellular vesicle-based bronchoalveolar lavage fluid liquid biopsy for EGFR mutation testing in advanced non-squamous NSCLC. Cancers (Basel), 14(11). https:\/\/doi.org\/10.3390\/cancers14112744","DOI":"10.3390\/cancers14112744"},{"issue":"3","key":"10367_CR153","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nm0398-336","volume":"4","author":"N Ferrara","year":"1998","unstructured":"Ferrara, N., et al. (1998). Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Medicine, 4(3), 336\u2013340. https:\/\/doi.org\/10.1038\/nm0398-336","journal-title":"Nature Medicine"},{"issue":"5827","key":"10367_CR154","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.1141478","volume":"316","author":"JA Engelman","year":"2007","unstructured":"Engelman, J. A., et al. (2007). MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science, 316(5827), 1039\u20131043. https:\/\/doi.org\/10.1126\/science.1141478","journal-title":"Science"},{"issue":"10","key":"10367_CR155","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa0810699","volume":"361","author":"TS Mok","year":"2009","unstructured":"Mok, T. S., et al. (2009). Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. New England Journal of Medicine, 361(10), 947\u2013957. https:\/\/doi.org\/10.1056\/NEJMoa0810699","journal-title":"New England Journal of Medicine"},{"issue":"36","key":"10367_CR156","doi-asserted-by":"publisher","first-page":"13306","DOI":"10.1073\/pnas.0405220101","volume":"101","author":"W Pao","year":"2004","unstructured":"Pao, W., et al. (2004). EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib. Proceedings of the National Academy of Sciences of the United States of America, 101(36), 13306\u201313311. https:\/\/doi.org\/10.1073\/pnas.0405220101","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"19","key":"10367_CR157","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck, M., et al. (2016). Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. New England Journal of Medicine, 375(19), 1823\u20131833. https:\/\/doi.org\/10.1056\/NEJMoa1606774","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10367_CR158","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/cei\/uxac045","volume":"208","author":"Y Wang","year":"2022","unstructured":"Wang, Y., et al. (2022). Exosomal PD-L1 predicts response with immunotherapy in NSCLC patients. Clinical and Experimental Immunology,208(3), 316\u2013322. https:\/\/doi.org\/10.1093\/cei\/uxac045","journal-title":"Clinical and Experimental Immunology"},{"issue":"12","key":"10367_CR159","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1158\/1078-0432.Ccr-17-3369","volume":"24","author":"E Castellanos-Rizaldos","year":"2018","unstructured":"Castellanos-Rizaldos, E., et al. (2018). Exosome-based detection of EGFR T790M in plasma from non-small cell lung cancer patients. Clinical Cancer Research, 24(12), 2944\u20132950. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-3369","journal-title":"Clinical Cancer Research"},{"issue":"6206","key":"10367_CR160","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1126\/science.1253462","volume":"346","author":"EC de Bruin","year":"2014","unstructured":"de Bruin, E. C., et al. (2014). Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science, 346(6206), 251\u2013256. https:\/\/doi.org\/10.1126\/science.1253462","journal-title":"Science"},{"issue":"10","key":"10367_CR161","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.jtho.2016.05.034","volume":"11","author":"B Sandfeld-Paulsen","year":"2016","unstructured":"Sandfeld-Paulsen, B., et al. (2016). Exosomal proteins as diagnostic biomarkers in lung cancer. Journal of Thoracic Oncology, 11(10), 1701\u20131710. https:\/\/doi.org\/10.1016\/j.jtho.2016.05.034","journal-title":"Journal of Thoracic Oncology"},{"issue":"11","key":"10367_CR162","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1001\/jamaoncol.2018.2969","volume":"4","author":"GR Oxnard","year":"2018","unstructured":"Oxnard, G. R., et al. (2018). Assessment of resistance mechanisms and clinical implications in patients with EGFR T790M-positive lung cancer and acquired resistance to osimertinib. JAMA Oncology, 4(11), 1527\u20131534. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2969","journal-title":"JAMA Oncology"},{"issue":"7","key":"10367_CR163","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1056\/NEJMoa1612674","volume":"376","author":"TS Mok","year":"2017","unstructured":"Mok, T. S., et al. (2017). Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer. New England Journal of Medicine, 376(7), 629\u2013640. https:\/\/doi.org\/10.1056\/NEJMoa1612674","journal-title":"New England Journal of Medicine"},{"issue":"7655","key":"10367_CR164","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature22364","volume":"545","author":"C Abbosh","year":"2017","unstructured":"Abbosh, C., et al. (2017). Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature,545(7655), 446\u2013451. https:\/\/doi.org\/10.1038\/nature22364","journal-title":"Nature"},{"issue":"1","key":"10367_CR165","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1038\/s41598-019-41800-2","volume":"9","author":"GK Patel","year":"2019","unstructured":"Patel, G. K., et al. (2019). Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications. Science and Reports, 9(1), 5335. https:\/\/doi.org\/10.1038\/s41598-019-41800-2","journal-title":"Science and Reports"},{"issue":"1","key":"10367_CR166","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s41598-020-57497-7","volume":"10","author":"K Brennan","year":"2020","unstructured":"Brennan, K., et al. (2020). A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum. Science and Reports, 10(1), 1039. https:\/\/doi.org\/10.1038\/s41598-020-57497-7","journal-title":"Science and Reports"},{"issue":"5","key":"10367_CR167","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70264","volume":"15","author":"BH Choi","year":"2026","unstructured":"Choi, B. H., et al. (2026). GCC2 in small extracellular vesicles as a diagnostic and prognostic biomarker of early-stage lung adenocarcinoma. J Extracell Vesicles, 15(5), Article e70264. https:\/\/doi.org\/10.1002\/jev2.70264","journal-title":"J Extracell Vesicles"},{"key":"10367_CR168","doi-asserted-by":"publisher","unstructured":"Tricard, J., et al. (2026). New proteomic signature in circulating extracellular vesicles from tumor-draining and peripheral veins of patients with lung adenocarcinoma. Cancer Cell International, 26(1). https:\/\/doi.org\/10.1186\/s12935-026-04264-9","DOI":"10.1186\/s12935-026-04264-9"},{"issue":"9","key":"10367_CR169","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm.2890","volume":"18","author":"Y Sun","year":"2012","unstructured":"Sun, Y., et al. (2012). Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nature Medicine,18(9), 1359\u20131368. https:\/\/doi.org\/10.1038\/nm.2890","journal-title":"Nature Medicine"},{"issue":"19","key":"10367_CR170","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1158\/0008-5472.Can-12-0925","volume":"72","author":"A Bobrie","year":"2012","unstructured":"Bobrie, A., et al. (2012). Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Research, 72(19), 4920\u20134930. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-0925","journal-title":"Cancer Research"},{"issue":"7659","key":"10367_CR171","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar, S., et al. (2017). Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature, 546(7659), 498\u2013503. https:\/\/doi.org\/10.1038\/nature22341","journal-title":"Nature"},{"issue":"50","key":"10367_CR172","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.1038\/s41388-021-02054-3","volume":"40","author":"P Bischoff","year":"2021","unstructured":"Bischoff, P., et al. (2021). Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma. Oncogene, 40(50), 6748\u20136758. https:\/\/doi.org\/10.1038\/s41388-021-02054-3","journal-title":"Oncogene"},{"key":"10367_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122097","volume":"297","author":"MC Keenum","year":"2023","unstructured":"Keenum, M. C., et al. (2023). Single-cell epitope-transcriptomics reveal lung stromal and immune cell response kinetics to nanoparticle-delivered RIG-I and TLR4 agonists. Biomaterials, 297, Article 122097. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122097","journal-title":"Biomaterials"},{"key":"10367_CR174","doi-asserted-by":"publisher","first-page":"17(1\u20132)","DOI":"10.1002\/pmic.201600243","volume":"17","author":"A Mossina","year":"2017","unstructured":"Mossina, A., et al. (2017). Cigarette smoke alters the secretome of lung epithelial cells. Proteomics, 17, 17(1\u20132). https:\/\/doi.org\/10.1002\/pmic.201600243","journal-title":"Proteomics"},{"key":"10367_CR175","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.lfs.2015.01.017","volume":"126","author":"C D'Anna","year":"2015","unstructured":"D\u2019Anna, C., et al. (2015). Cigarette smoke alters cell cycle and induces inflammation in lung fibroblasts. Life Sciences, 126, 10\u201318. https:\/\/doi.org\/10.1016\/j.lfs.2015.01.017","journal-title":"Life Sciences"},{"key":"10367_CR176","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.freeradbiomed.2018.10.450","volume":"130","author":"A Cruz-Berm\u00fadez","year":"2019","unstructured":"Cruz-Berm\u00fadez, A., et al. (2019). Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-\u03b2 signaling. Free Radical Biology & Medicine, 130, 163\u2013173. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.10.450","journal-title":"Free Radical Biology & Medicine"},{"issue":"3","key":"10367_CR177","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.celrep.2016.09.031","volume":"17","author":"L Santangelo","year":"2016","unstructured":"Santangelo, L., et al. (2016). The RNA-binding protein SYNCRIP is a component of the hepatocyte exosomal machinery controlling microRNA sorting. Cell Reports,17(3), 799\u2013808. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.031","journal-title":"Cell Reports"},{"issue":"Pt 24","key":"10367_CR178","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1242\/jcs.128868","volume":"126","author":"M Colombo","year":"2013","unstructured":"Colombo, M., et al. (2013). Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. Journal of Cell Science, 126(Pt 24), 5553\u20135565. https:\/\/doi.org\/10.1242\/jcs.128868","journal-title":"Journal of Cell Science"},{"issue":"1","key":"10367_CR179","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2017.1388731","volume":"6","author":"K Takov","year":"2017","unstructured":"Takov, K., Yellon, D. M., & Davidson, S. M. (2017). Confounding factors in vesicle uptake studies using fluorescent lipophilic membrane dyes. J Extracell Vesicles, 6(1), Article 1388731. https:\/\/doi.org\/10.1080\/20013078.2017.1388731","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"10367_CR180","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","volume":"177","author":"M Poggio","year":"2019","unstructured":"Poggio, M., et al. (2019). Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory. Cell, 177(2), 414-427.e13. https:\/\/doi.org\/10.1016\/j.cell.2019.02.016","journal-title":"Cell"},{"key":"10367_CR181","doi-asserted-by":"publisher","unstructured":"Sachs, N., et al. (2019). Long-term expanding human airway organoids for disease modeling. The Embo Journal, 38(4). https:\/\/doi.org\/10.15252\/embj.2018100300","DOI":"10.15252\/embj.2018100300"},{"issue":"3","key":"10367_CR182","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nm.4040","volume":"22","author":"AN Hata","year":"2016","unstructured":"Hata, A. N., et al. (2016). Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition. Nature Medicine, 22(3), 262\u2013269. https:\/\/doi.org\/10.1038\/nm.4040","journal-title":"Nature Medicine"},{"issue":"17","key":"10367_CR183","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1158\/1078-0432.Ccr-15-2449","volume":"22","author":"A Sharma","year":"2016","unstructured":"Sharma, A., et al. (2016). Secretome signature identifies ADAM17 as novel target for radiosensitization of non-small cell lung cancer. Clinical Cancer Research, 22(17), 4428\u20134439. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-2449","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10367_CR184","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41416-023-02491-9","volume":"130","author":"SZ Eslami","year":"2024","unstructured":"Eslami, S. Z., et al. (2024). Circulating tumour cells and PD-L1-positive small extracellular vesicles: The liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer. British Journal of Cancer,130(1), 63\u201372. https:\/\/doi.org\/10.1038\/s41416-023-02491-9","journal-title":"British Journal of Cancer"},{"issue":"12","key":"10367_CR185","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1158\/2159-8290.Cd-17-0716","volume":"7","author":"AA Chaudhuri","year":"2017","unstructured":"Chaudhuri, A. A., et al. (2017). Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discovery, 7(12), 1394\u20131403. https:\/\/doi.org\/10.1158\/2159-8290.Cd-17-0716","journal-title":"Cancer Discovery"},{"key":"10367_CR186","doi-asserted-by":"publisher","unstructured":"Ostrowski, M., et al. (2010). Rab27a and Rab27b control different steps of the exosome secretion pathway. Nature Cell Biology, 12(1), 19\u201330; sup pp 1\u201313. https:\/\/doi.org\/10.1038\/ncb2000","DOI":"10.1038\/ncb2000"},{"issue":"1","key":"10367_CR187","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1021\/acsnano.7b07782","volume":"12","author":"Y Tian","year":"2018","unstructured":"Tian, Y., et al. (2018). Protein profiling and sizing of extracellular vesicles from colorectal cancer patients via flow cytometry. ACS Nano, 12(1), 671\u2013680. https:\/\/doi.org\/10.1021\/acsnano.7b07782","journal-title":"ACS Nano"},{"issue":"8","key":"10367_CR188","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts, D., et al. (2018). Phenotype molding of stromal cells in the lung tumor microenvironment. Nature Medicine,24(8), 1277\u20131289. https:\/\/doi.org\/10.1038\/s41591-018-0096-5","journal-title":"Nature Medicine"},{"issue":"5","key":"10367_CR189","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.cell.2020.07.017","volume":"182","author":"A Maynard","year":"2020","unstructured":"Maynard, A., et al. (2020). Therapy-induced evolution of human lung cancer revealed by single-cell RNA sequencing. Cell, 182(5), 1232-1251.e22. https:\/\/doi.org\/10.1016\/j.cell.2020.07.017","journal-title":"Cell"},{"issue":"1","key":"10367_CR190","doi-asserted-by":"publisher","first-page":"10164","DOI":"10.1038\/s41467-024-54434-4","volume":"15","author":"KJ Song","year":"2024","unstructured":"Song, K. J., et al. (2024). Proteogenomic analysis reveals non-small cell lung cancer subtypes predicting chromosome instability, and tumor microenvironment. Nature Communications, 15(1), 10164. https:\/\/doi.org\/10.1038\/s41467-024-54434-4","journal-title":"Nature Communications"},{"issue":"1","key":"10367_CR191","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2020.06.013","volume":"182","author":"MA Gillette","year":"2020","unstructured":"Gillette, M. A., et al. (2020). Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell, 182(1), 200-225.e35. https:\/\/doi.org\/10.1016\/j.cell.2020.06.013","journal-title":"Cell"},{"issue":"12","key":"10367_CR192","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1158\/1078-0432.Ccr-19-3418","volume":"26","author":"MD Hellmann","year":"2020","unstructured":"Hellmann, M. D., et al. (2020). Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC. Clinical Cancer Research, 26(12), 2849\u20132858. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-3418","journal-title":"Clinical Cancer Research"},{"key":"10367_CR193","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2147\/ott.S428707","volume":"16","author":"X Wan","year":"2023","unstructured":"Wan, X., et al. (2023). GW4869 can inhibit epithelial-mesenchymal transition and extracellular HSP90\u03b1 in gefitinib-sensitive NSCLC cells. OncoTargets and Therapy, 16, 913\u2013922. https:\/\/doi.org\/10.2147\/ott.S428707","journal-title":"OncoTargets and Therapy"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10367-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-026-10367-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10367-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:26:42Z","timestamp":1786588002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-026-10367-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":193,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["10367"],"URL":"https:\/\/doi.org\/10.1007\/s10555-026-10367-6","relation":{},"ISSN":["1573-7233"],"issn-type":[{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":5,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"56"}}